Pictet Asset Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Pictet Asset Management's LLY Position: Q2 2026 in Review
Pictet Asset Management reduced its Eli Lilly (LLY) stake by 20% in Q2 2026, selling an estimated $193M and leaving 754,985 shares worth $906M. The position accounts for 0.87% of the portfolio, ranked #18.
Pictet Asset Management first reported a position in LLY in Q3 2023 and has held it in 12 quarters since. The position peaked at $946M in Q4 2025. 4,623 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Pictet Asset Management held 754,985 shares of Eli Lilly worth $906M as of Q2 2026.
- Pictet Asset Management sold 188,991 Eli Lilly shares in Q2 2026, an estimated $193M.
- Eli Lilly made up 0.87% of Pictet Asset Management's portfolio in Q2 2026, its #18 holding.
- Pictet Asset Management first reported a position in Eli Lilly in Q3 2023 and has held it in 12 quarters since.
- Pictet Asset Management's Eli Lilly position peaked at $946M in Q4 2025.
- 4,623 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Pictet Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.